Background
==========

In 1939, Levine and Stetson discovered the human Rh blood group system, and their study has proven that this system is one of the most critical blood group systems next to the ABO system in clinical importance \[[@b1-medscimonit-26-e921058],[@b2-medscimonit-26-e921058]\]. After 2 of the Rh gene cDNAs were cloned in 1990 \[[@b2-medscimonit-26-e921058],[@b3-medscimonit-26-e921058]\], the study of the genetic structure of the Rh blood group system rapidly progressed.

As one of the most polymorphic systems of the human blood, the Rh blood group system consists of more than 50 antigens \[[@b4-medscimonit-26-e921058],[@b5-medscimonit-26-e921058]\]. However, only 5 antigens are particularly important in clinical practice, and the antigenicity from strong to weak is as follows: D\>E\>C\>c\>e \[[@b5-medscimonit-26-e921058],[@b6-medscimonit-26-e921058]\]. If the Rh antigen-antibody system does not match between the blood donor and the receptor, this might cause a hemolytic transfusion reaction, newborns hemolytic disease (HDN), and autoimmune hemolytic anemia \[[@b7-medscimonit-26-e921058],[@b8-medscimonit-26-e921058]\]. At present, the essential antigens D are commonly detected in every hospital of China and in the world, but only a few have detected the other 4 significant antigens, which might be the most crucial cause of immunoreaction.

Our department started to detect the Rh serological phenotype in patients who might need 2 or more blood transfusions, developed the component blood infusion of the same ABO and 5 major antigens of Rh phenotypes since 2013, and generalized the detection to all patients who might need blood transfusion since 2015. The results revealed that the rate from a high level was D, e, C, c, and E, which was in accordance with the reports of previous studies in other populations \[[@b9-medscimonit-26-e921058]\].

After the component blood infusion of consistent ABO and the 5 major Rh antigen types, the adverse effects of blood transfusion in our hospital decreased year by year, from 19.95% in 2012 to 3.098% in 2019, and considerably lowered the occurrence rate. Furthermore, the detection rate of unexpected antibodies gradually increased from 0.18% in 2014 to 0.56% in 2019, while the detection rate of unexpected antibodies slowly decreased in the Rh system in antibody-positive patients, from 72.41% in 2014 to 39.76% in 2019. All these results prove the great importance of Rh homotypic infusion in clinical practice.

Material and Methods
====================

Samples
-------

Approximately 77 180 donor blood samples were supplied by the Blood Center from 2011 to June 2019, and donors who donated 2 times or more were counted as 1 donation using the Blood Center ID numbers. Patients who might need a blood transfusion and applied for it were enrolled in the study. We enrolled 90 891 patients from 2011 to June 2019 in the present study. The total number of samples was 168 071. Adverse effects of patients who received blood transfusions were analyzed in this period at the hospital.

Instruments and reagents
------------------------

For the indirect anti-globulin assay, micro-column gel cards were purchased from Diana Company. The Rh blood group system appraisal instruments and reagents were obtained from Changchun Company. Spectrum cells (a set of 16) were obtained from Shanghai Blood Biological Medicine Company. Other instruments included the incubation (Diana Company) and centrifugation (BASO Company) process.

Methods
-------

The Rh serological phenotypes of the main 5 antigens in all donors and receptors were detected according to manufacturer's protocols. The irregular antibody specificity of positive samples with the 1 ball micro-column gel method was further identified using the brine and people indirect anti-globulin methods. Patients who received at least 2 blood transfusions were regarded as the same subject using their unique hospital ID number when analyzing the infusion adverse reactions. The same donors and receptors were taken once when analyzing the Rh serological phenotype with the Blood Center ID number. All results were independently checked by 2 staff.

Statistical analysis
--------------------

All data are presented as mean±standard deviation (SD), and Student's unpaired or paired *t*-test was performed, as appropriate, to compare differences between groups. The Mann-Whitney *U*-test was performed to compare the non-parametric data between the 2 study groups. A *P*-value \<0.05 was considered statistically significant. The data were analyzed using GraphPad Prism 5 software (Graph Pad Software, Inc., San Diego, CA, USA).

Results
=======

The distribution of Rh phenotypes in subjects
---------------------------------------------

The blood in our hospital was routinely donated by the Blood Center of Zhejiang Province, and this is the only department entitled to provide blood for the hospital. From January 2011 to June 2019, a total of 77 180 blood products were sent to the hospital. There were 90 891 inpatients who might need transfusions. Repetitions were eliminated using the Blood Center ID numbers on the blood bags for donors and the hospital ID number for inpatients. All 168 071 subjects were detected for both the ABO and 5 major Rh serological antigens. Among these subjects, a total of 15 phenotypes were detected. Among these, CCDee was the highest in frequency (44.944%), followed by CcDEe (34.014%), CcDee (8.679%), ccDEE (7.123%), and ccDEe (3.338%). The detailed information is summarized in [Table 1](#t1-medscimonit-26-e921058){ref-type="table"}. The serological antigen "D" negative was written as "d".

The antigen distribution of the Rh blood group system in donors
---------------------------------------------------------------

For all donors, the ratio of these 4 ABO types was as follows: A 30.530%, B 28.478%, O 32.244%, and AB 8.748%. For patients, the ratio was as follows: A 31.417%, B 25.632%, O 34.563%, and AB 8.32%. These results are consistent with those in previous studies \[[@b10-medscimonit-26-e921058],[@b11-medscimonit-26-e921058]\]. There were almost twice as many male donors as female donors. Type "O" was the most common type in Rh (D) positive and negative phenotypes among males and females. The type, along with the other 4 major Rh antigens, was detected in 77 180 donors. Among these donors, 76 636 (99.295%) donors were RhD, and 544 (0.705%) donors were Rhd. In terms of the type of RhD, the CCDee phenotype was the most common type, while in Rhd, this was ccdee. The results are presented in [Table 2](#t2-medscimonit-26-e921058){ref-type="table"}.

Antigen detection of the Rh blood group system in patients
----------------------------------------------------------

For patients, the ratio of the 4 ABO types was almost the same as that of donors, but the percentage for females was much higher than that for donors. Type "O" continued to be the most common type among patients in our hospital. The RhD type, along with other major Rh antigens, was detected in 90 891 patients. Among these patients, 90 511 (99.582%) patients were RhD and 380 (0.418%) patients were Rhd. For the type of RhD, the CCDee type was the major type, while for Rhd, the major type was ccdee, and this was consistent with that of the blood donors. The results are presented in [Table 3](#t3-medscimonit-26-e921058){ref-type="table"}.

The adverse reaction of transfusion from 2011 to Jun 2019
---------------------------------------------------------

In China, every hospital must comply with the principles of homotypic ABO and RhD infusion for patients who need routine blood transfusions, which is the same for our hospital since before 2013. The investigators started to detect the 5 major antigens of the Rh serological phenotype in patients who might need blood transfusions at least 2 times or more. Then, the component blood infusion was prepared with the same ABO and Rh serological phenotype since October 2013, and the detection was generalized for all patients who needed blood transfusions since October 2014. The total number of infusions for patients from 2011 to June 2019 was 3108, 3329, 4283, 4585, 4871, 4885, 4092, 4373, and 2444, respectively. The number of adverse effects of blood transfusion was 62, 58, 37, 36, 18, 17, 12, 13, and 8, respectively. The adverse effects of blood transfusion in our hospital have decreased year by year: 19.95%, 17.42%, 8.69%, 7.85%, 3.69%, 3.49%, 3.016%, 3.126%, and 3.098%. This proves the delicate relationship between the homotypic Rh transfusion and the adverse effects of blood transfusion. The results are presented in [Figure 1](#f1-medscimonit-26-e921058){ref-type="fig"}. The study investigated the type of adverse effects involving transfusion of different Rh phenotype, and the results are shown in [Supplementary Table 1](#s1-medscimonit-26-e921058){ref-type="supplementary-material"}.

We also assessed the rates of adverse effects among patients who received homotypic infusion and the patients who did not receive homotypic infusion from 2015 to Jun 2019 (as before October 2014 we did not detect all the patients' Rh serological phenotype). The results showed that there is a statistically significant difference between the 2 groups (*P* \<0.05) ([Supplementary Table 2](#s2-medscimonit-26-e921058){ref-type="supplementary-material"}).

Distribution of the 5 major Rh antigens
---------------------------------------

In the present study, the distribution of the 4 major Rh antigens in Rh (D) positive and negative subjects was analyzed. Interestingly, the most significant difference was the percentage of C and c: C was much higher than c in RhD, while c was much higher than C in Rhd. There was no EE in Rhd in the present study. Furthermore, the present study analyzed the antigen frequency (AF) of the 5 major Rh antigens ([Table 4](#t4-medscimonit-26-e921058){ref-type="table"}). It was noteworthy that AF is an extremely important clinical indicator for predicting the common alloantibodies that could be formed in patients after receiving repeated transfusions, thereby contributing to the selection of antigen-negative blood for patients with alloantibodies \[[@b12-medscimonit-26-e921058]\]. This is in accordance with studies on multi-transfused thalassemias and hemodialysis patients published from a center in north India \[[@b13-medscimonit-26-e921058],[@b14-medscimonit-26-e921058]\].

The correlation among the 5 major antigens of Rh blood transfusions with different antibodies detection
-------------------------------------------------------------------------------------------------------

Since our department started to detect the Rh serological phenotype of patients who might need blood transfusion in 2013, the accordance of Rh infusion was stable after 2015, since Rh 5 major antigens were detected in all patients. The rates of the Rh 5 major antigens, in accordance with the transfusion (accordance of Rh) from 2013 to June 2019, were 67.3%, 73.7%, 90.1%, 89.7%, 90.0%, 92.8%, and 92.3%, respectively. The results of the irregular antibody detection revealed that the positive rate gradually increased (0.15%, 0.18%, 0.16%, 0.26%, 0.38%, 0.54%, and 0.56%, respectively), while the Rh system antibody-positive rate decreased (59.13%, 72.41%, 55.56%, 55.56%, 47.14%, 40.90%, and 39.76%, respectively). In addition, a negative correlation was observed between the accordance of the Rh and positive rate of Rh antibody detection (P=0.0167, r=0.9747). In the further analysis of the Rh system antibody, it was found that the E antibody-positive rate was very high: 59.53%, 58.62%, 48.14%, 42.28%, 41.43%, 32.73%, and 31.89%, respectively. There was also a correction between the accordance of the Rh and the positive rate of E antibody detection (P=0.0833, r=0.9000). All these results are presented in [Figures 2](#f2-medscimonit-26-e921058){ref-type="fig"} and [3](#f3-medscimonit-26-e921058){ref-type="fig"}. In the study, we analysis the antibody-positive patients according to the body system, and found that the proportion of circulatory system and digestive system was relatively higher than in the other 6 systems, and the difference was statistically different (p\<0.05) ([Supplementary Table 3](#s3-medscimonit-26-e921058){ref-type="supplementary-material"}).

Discussion
==========

The Rh blood group is generally recognized as the second most crucial system in transfusion medicine after the ABO blood type \[[@b1-medscimonit-26-e921058],[@b2-medscimonit-26-e921058]\]. The present study statistically analyzed the distribution difference of the Rh serological phenotype in the population of Hangzhou, Zhejiang province, to determine the necessity of its clinical routine detection and homotypic infusion. We enrolled 168 071 subjects, and the ABO and 5 major Rh serological antigens were detected. Then, the adverse effects of blood transfusions from 2011 to June 2019 in our hospital were compared. The results reveal that this has a large effect in lowering the adverse effects after the same Rh phenotype infusion.

The antigen frequency of RhD-positive subjects in the present study was 99.450%, while the frequencies of the other Rh antigens were C 88.872%, c 54.226%, E 45.517%, and e 92.654%. This was in line with previous studies \[[@b9-medscimonit-26-e921058],[@b15-medscimonit-26-e921058]\]. Although antigen D is the most potent immunogen, the AF of the other 4 antigens in this system remained much higher. This can also stimulate the immune system to produce clinically significant antibodies when receiving an infusion of red cells with Rh D, which are compatible and incompatible for C, c, E, or e antigens. However, this might lead to adverse effects from the blood transfusion \[[@b16-medscimonit-26-e921058]\]. Moreover, the specific antibodies of this system were the most frequent antibodies encountered in the pretransfusion testing, which remains the most important reason for hemolytic disease of newborns (HDN) \[[@b17-medscimonit-26-e921058]\].

In the present study, the most common Rh type was CCDee, both in donors and patients, while CcDEe was in second place. These results agree with previously published studies \[[@b9-medscimonit-26-e921058],[@b18-medscimonit-26-e921058]\]. Since these 2 types could reach up to 79.08% in total, these may be a critical factor for the production of alloantibodies and adverse effects of blood transfusion. A total of 27 patients who had adverse effects after blood transfusion in our hospital before 2013 were contacted, and the blood type of the Rh 5 significant phenotypes was analyzed. Among these 27 patients, 15 were CCDee, 9 were CcDee, and 3 were ccDEE. All these patients were given red blood cells of CcDEe. After the development of the homotypic infusion of the Rh 5 major antigens in our department, a decrease in the incident rate of adverse effects was apparent and obvious ([Figure 1](#f1-medscimonit-26-e921058){ref-type="fig"}). All these results show that there is an excellent relationship between the Rh blood group and incidence of adverse effects when there was an incompatible infusion with C, c, E, or e antigens. In addition, some studies reported that the matching for pure antigens (D, C, E, c, e, K, and possibly Fya, Jka, and Jkb) would be successful in preventing alloimmunization in the vast majority of sickle cell disease (SCD) patients \[[@b19-medscimonit-26-e921058]\]. The investigators considered that the rate of adverse effects is very stable at 3%, which might be due to the probability that antigens K, Fya, Jka, and Jkb are not compatible when transfused.

There was a decrease in irregular antibody detection after the accordance of Rh. The accordance of Rh was stable at above 90% after the 2015, but the positive rate of irregular antibody detection increased year by year. These analysis results also show there is a correlation between the accordance of Rh and the positive rate of irregular antibody detection, especially the relationship between the accordance of Rh and the Rh antibody detection. The positive rate of Rh antibody detection decreased after 2015, and the correlation with the accordance of Rh was statistically significant. Also, there is a significant difference (p\<0.05) in the antibody-positive patients in 8 body systems. As this type of disease is so diverse, it is hard to say which disease easily produces antibody. All these results show that this work has a great effect on patients.

The Duffy antigen is encoded by the FY gene, and the Fya and Fyb antigens are encoded by the FY01 and FY02 alleles \[[@b20-medscimonit-26-e921058]\]. A rearranged RhD allele can encode an altered D antigen, which is the so-called partial D antigen, and an individual homozygous for the rearranged RhD allele or compound heterozygous in trans-silenced RhD allele can produce the anti-D alloantibody \[[@b21-medscimonit-26-e921058]\]. The present study took the partial D antigen as RhD-positive for donors and as RhD-negative for patients. Hence, there is no partial D antigen in the present study.

Limitations of the present study
--------------------------------

The major limitation of this study was that only the Rh phenotype and not the Rh genotype of the subjects was tested, but the results are beneficial for clinical work. The other limitation is that there was a higher representation of males in the donors (almost twice the number of females), which is very good for the patients, as the females might have a high antibody rate.

Conclusions
===========

The present study provides guidance in establishing a database of Rh distribution in the population of Hangzhou, Zhejiang province. These results imply that the same Rh phenotype infusion might contribute to the reduction in the incidence rate of adverse effects, and that attention should be focussed not only on the ABO system and RhD phenotype, but also on the other 4 antigens of Rh (C, c, E, and e). The present study can be further extended in the future to include molecular investigations. Finally, merely serological investigations were performed. Molecular probes would be more informative, and should be performed in the future.

Supplementary Data
==================

###### 

Adverse events involving transfusion of different Rh phenotype 2015 to Jun 2019.

  Year        Accordance of Rh   Unaccordance of Rh                                  
  ----------- ------------------ -------------------- -------- ---------- ---------- --------
  2015        4871               4389                 14       482        90.1       4
  2016        4885               4382                 13       503        89.7       4
  2017        4092               3656                 11       436        90         1
  2018        4373               4058                 12       315        92.8       1
  2019.6      2444               2256                 7        188        92.3       1
  **Total**   **20665**          **18741**            **57**   **1924**   **90.7**   **11**

###### 

Adverse effects among the patients who received homotypic infusion and the patients who did not receive homotypic infusion from 2015 to Jun 2019.

  Year        Number of receptors   Accordance of Rh   Accordance rate of Rh (%)   Discordance of Rh                                  
  ----------- --------------------- ------------------ --------------------------- ------------------- ---------- ---------- -------- ----------
  2015        4871                  4389               14                          3.18                90.1       482        4        8.3
  2016        4885                  4382               13                          2.96                89.7       503        4        7.95
  2017        4092                  3656               10                          2.74                90         436        2        4.59
  2018        4373                  4058               12                          2.96                92.8       315        1        3.17
  2019.6      2444                  2256               7                           3.1                 92.3       188        1        5.32
  **Total**   **20665**             **18741**          **56**                      **3.04**            **90.7**   **1924**   **12**   **5.72**

###### 

Distribution of antibody-positive patients in the 8 body systems from 2015 to June 2019.

  Type of system       Antibody positive   Antibody negative   Antibody positive rate (‰)
  -------------------- ------------------- ------------------- ----------------------------
  Circulatory system   73                  2912                24.46
  Digestive system     69                  2808                23.98
  Motor system         39                  2637                14.57
  Respiratory system   33                  2548                12.79
  Urinary system       27                  2359                11.32
  Genital system       18                  2267                7.88
  Nervous system       30                  2411                12.29
  Endocrine system     25                  2409                10.27
  **Total**            **314**             **20351**           **15.19**
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![The number of receptors and adverse incidences from 2011 to June 2009: With the increase in the number of receptors year by year, the adverse incidence rate decreased from 19.95% to 3.098% after the same Rh serological phenotype infusion, which remained very stable each year. The "2019.6" refers to the period from January to June 2019.](medscimonit-26-e921058-g001){#f1-medscimonit-26-e921058}

![The results of the rate of the Rh 5 major antigens accordance transfusion (accordance of Rh) and the irregular antibody detection: The accordance of Rh was stable at above 90% after 2015, but the positive rate of irregular antibody detection increased year by year. The correlation between the accordance of Rh and the positive rate of irregular antibody detection was not statistically significant (*P*=0.2333, r=0.7000).](medscimonit-26-e921058-g002){#f2-medscimonit-26-e921058}

![The results of the accordance of Rh and Rh antibody detection: The positive rate of the Rh antibody detection decreased after 2015, and the correlation with the accordance of Rh was statistically significant (*P*=0.0176, r=0.9747). The E antibody of the Rh system was the major antibody. The study results revealed that the correlation with the accordance of Rh was not statistically significant (*P*=0.0833, r=0.9000).](medscimonit-26-e921058-g003){#f3-medscimonit-26-e921058}

###### 

The serological phenotypes of the 5 major antigens in the Rh blood type of all subjects.

  No.   Rh phenotype   Frequency   Percentage (%)
  ----- -------------- ----------- ----------------
  1     CDe/CDe        75541       44.944
  2     CDE/cDe        57170       34.014
  3     CDe/cDe        14587       8.679
  4     cDE/cDE        11973       7.123
  5     cDE/cDe        5610        3.338
  6     CDE/CDe        1317        0.784
  7     cDe/cDe        576         0.343
  8     cde/cde        506         0.301
  9     CDE/cDE        357         0.212
  10    Cde/cde        304         0.181
  11    Cde/Cde        56          0.033
  12    cdE/cde        38          0.023
  13    CDE/CDE        16          0.010
  14    CdE/cde        18          0.011
  15    CdE/Cde        2           0.001

###### 

The distribution of the Rh blood group system antigen detection in donors.

  RH          ABO                                                                                        
  ----------- ----------- ---------- ----------- ---------- ----------- ---------- ---------- ---------- -----------
  CCDee       7032        3547       6537        3459       7452        3721       2082       1082       **34912**
  CcDEe       5090        2885       4767        2586       5759        2606       1355       809        **25857**
  CcDee       1379        723        1236        604        1466        637        352        189        **6586**
  ccDEE       1188        492        1078        510        1241        601        293        164        **5567**
  ccDEe       524         237        464         324        562         286        157        102        **2656**
  CCDEe       108         49         101         46         130         68         33         29         **564**
  ccDee       57          26         60          21         63          30         20         9          **286**
  CcDEE       32          19         36          26         47          20         8          11         **199**
  ccdee       59          41         37          31         63          36         20         17         **304**
  Ccdee       25          27         23          16         42          30         8          7          **178**
  CCdee       9           5          2           6          3           2          2          1          **30**
  ccdEe       1           0          3           1          7           7          0          0          **19**
  CcdEe       3           1          1           2          0           3          1          1          **12**
  CCDEE       3           1          1           1          1           2          0          0          **9**
  CCdEe       0           0          0           0          0           1          0          0          **1**
  **Total**   **15510**   **8053**   **14346**   **7633**   **16836**   **8050**   **4331**   **2421**   **77180**

###### 

The antigen distribution of the Rh blood group system in patients.

  RH          ABO                                                                                           
  ----------- ----------- ----------- ----------- ----------- ----------- ----------- ---------- ---------- -----------
  CCDee       7155        5622        5741        4523        7952        6222        1931       1483       **40629**
  CcDEe       5481        4332        4464        3657        6098        4607        1468       1206       **31313**
  CcDee       1399        1134        1149        933         1542        1206        362        276        **8001**
  ccDEE       1191        843         937         721         1238        961         304        211        **6406**
  ccDEe       493         390         448         335         603         428         141        116        **2954**
  CCDEe       154         94          108         83          148         101         33         32         **753**
  ccDee       51          36          43          39          62          42          8          9          **290**
  CcDEE       28          22          26          12          35          24          5          6          **158**
  ccdee       30          38          22          20          38          38          6          10         **202**
  Ccdee       16          24          14          10          25          24          6          7          **126**
  CCdee       9           4           2           1           5           3           1          1          **26**
  ccdEe       4           1           3           2           3           4           1          1          **19**
  CCDEE       2           0           1           2           0           2           0          0          **7**
  CcdEe       1           0           1           0           3           1           0          0          **6**
  CCdEe       1           0           0           0           0           0           0          0          **1**
  **Total**   **16015**   **12540**   **12959**   **10338**   **17752**   **13663**   **4266**   **3358**   **90891**

###### 

The antigen frequency (AF) of other Rh antigens (C, c, E, and e) in Rh (D) positive and negative objects in the study.

  Number of objects          [C]{.ul} AF (%)   [c]{.ul} AF (%)   [E]{.ul} AF (%)   [e]{.ul} AF (%)
  -------------------------- ----------------- ----------------- ----------------- -----------------
  Rh (D) positive (167147)   89.136            54.008            45.734            92.614
  Rh (D) negative (924)      41.126            93.723            6.280             100.000
  Total (168071)             88.872            54.226            45.517            92.654
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